Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
85.53
-1.81 (-2.07%)
Jan 2, 2026, 2:12 PM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Peptide Therapeutics
434.43M
Log In
Log In
Log In
Log In
Upgrade
Peptide Therapeutics Growth
624.05%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States
434.43M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
624.05%
Log In
Log In
Log In
Log In
Upgrade